News
Specialty Drug Prices Offset Measures to Lower Medicare Patient Costs
September 8, 2016
Featured Experts: Erin Trish, PhD, Geoffrey Joyce, PhD
Research
All Research Featured Research
Perspective
To Prevent Another EpiPen Controversy, the Government Should Step In
August 29, 2016
Featured Experts: Dana Goldman, PhD
Perspective
Clinton and Trump are Both Wrong about Medicare’s Ability to Negotiate Drug Prices
August 13, 2016
Featured Experts: Geoffrey Joyce, PhD, Neeraj Sood, PhD
Journal Article
Why Medicare Price Negotiation Is the Wrong Prescription for Rising Drug Spending
August 11, 2016
Featured Experts: Geoffrey Joyce, PhD, Neeraj Sood, PhD
Journal Article
Optimizing HCV Treatment: Moving Beyond the Cost Conundrum
July 30, 2016
Featured Experts: Jason Doctor, PhD
Journal Article
Impact of Type 2 Diabetes Medication Cost Sharing on Patient Outcomes and Health Plan Costs
June 30, 2016
Featured Experts: Seth Seabury, PhD, Dana Goldman, PhD
Journal Article
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection
June 30, 2016
Featured Experts: Seth Seabury, PhD, Dana Goldman, PhD, Darius Lakdawalla, PhD
Journal Article
The Impact of Delayed Hepatitis C Viral Load Suppression on Patient Risk: Historical Evidence from the Veterans Administration
June 15, 2016
Featured Experts: Steven Fox, MD, MSc
Journal Article
Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events
June 1, 2016
Featured Experts: Dana Goldman, PhD
Journal Article
Competing Risks: Investing in Sickness Rather Than Health
June 1, 2016
Featured Experts: Dana Goldman, PhD
Journal Article
Estimating the Lifetime Price of Pharmaceuticals: What Are the Long-Term Costs to Society?
May 31, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Does Patient Cost Sharing for HCV Drugs Make Sense?
May 3, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Value of Expanding HCV Screening and Treatment Policies in the United States
May 1, 2016
Featured Experts: Darius Lakdawalla, PhD, Karen Mulligan, PhD
Journal Article
The Wider Public Health Value of HCV Treatment Accrued by Liver Transplant Recipients
May 1, 2016
Featured Experts: Darius Lakdawalla, PhD
Journal Article
Costs and Spillover Effects of Private Insurers’ Coverage of Hepatitis C Treatment
May 1, 2016
Featured Experts: Karen Mulligan, PhD, Darius Lakdawalla, PhD
Evidence Base
What the Candidates Don’t Get About Drug Prices
March 19, 2016
Featured Experts: Dana Goldman, PhD